BG106115A - Синергичните ефекти на амлодипин и аторвастатин метаболит като база за комбинирана терапия - Google Patents
Синергичните ефекти на амлодипин и аторвастатин метаболит като база за комбинирана терапия Download PDFInfo
- Publication number
- BG106115A BG106115A BG106115A BG10611501A BG106115A BG 106115 A BG106115 A BG 106115A BG 106115 A BG106115 A BG 106115A BG 10611501 A BG10611501 A BG 10611501A BG 106115 A BG106115 A BG 106115A
- Authority
- BG
- Bulgaria
- Prior art keywords
- pharmaceutical composition
- amlodipine
- organs
- blood pressure
- lipid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13066599P | 1999-04-23 | 1999-04-23 | |
US14530599P | 1999-07-23 | 1999-07-23 | |
US15112199P | 1999-08-27 | 1999-08-27 | |
US16659299P | 1999-11-19 | 1999-11-19 | |
PCT/US2000/010465 WO2000064443A1 (en) | 1999-04-23 | 2000-04-18 | Synergistic effects of amlodipine and atorvastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
BG106115A true BG106115A (bg) | 2002-11-29 |
Family
ID=27494873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG106115A BG106115A (bg) | 1999-04-23 | 2001-11-16 | Синергичните ефекти на амлодипин и аторвастатин метаболит като база за комбинирана терапия |
Country Status (30)
Country | Link |
---|---|
EP (1) | EP1173172B1 (de) |
JP (1) | JP2002542289A (de) |
KR (1) | KR20020024581A (de) |
CN (1) | CN1351492A (de) |
AP (1) | AP2001002324A0 (de) |
AT (1) | ATE314846T1 (de) |
AU (1) | AU4647000A (de) |
BG (1) | BG106115A (de) |
BR (1) | BR0010689A (de) |
CA (1) | CA2370639A1 (de) |
CZ (1) | CZ20013793A3 (de) |
DE (1) | DE60025344T2 (de) |
DK (1) | DK1173172T3 (de) |
EA (1) | EA004435B1 (de) |
EE (1) | EE200100555A (de) |
ES (1) | ES2256005T3 (de) |
HK (1) | HK1043741A1 (de) |
HU (1) | HUP0201016A3 (de) |
IL (1) | IL146085A0 (de) |
IS (1) | IS6118A (de) |
NO (1) | NO20015128L (de) |
OA (1) | OA11870A (de) |
PE (1) | PE20010055A1 (de) |
PL (1) | PL351408A1 (de) |
PT (1) | PT1173172E (de) |
SK (1) | SK15382001A3 (de) |
SV (1) | SV2002000058A (de) |
TN (1) | TNSN00085A1 (de) |
UY (1) | UY26118A1 (de) |
WO (1) | WO2000064443A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030114497A1 (en) * | 2001-07-31 | 2003-06-19 | Laman Alani | Pharmaceutical compositions of amlodipine and atorvastatin |
CN100430057C (zh) * | 2005-04-08 | 2008-11-05 | 石药集团中奇制药技术(石家庄)有限公司 | 左旋氨氯地平和阿托伐他汀的药物组合物 |
KR101467110B1 (ko) * | 2013-08-01 | 2014-11-28 | 한국방송공사 | 코로나링을 구비한 지선애자 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5385929A (en) * | 1994-05-04 | 1995-01-31 | Warner-Lambert Company | [(Hydroxyphenylamino) carbonyl] pyrroles |
GT199800127A (es) * | 1997-08-29 | 2000-02-01 | Combinaciones terapeuticas. |
-
2000
- 2000-04-18 KR KR1020017013547A patent/KR20020024581A/ko not_active Application Discontinuation
- 2000-04-18 CZ CZ20013793A patent/CZ20013793A3/cs unknown
- 2000-04-18 PL PL00351408A patent/PL351408A1/xx unknown
- 2000-04-18 AU AU46470/00A patent/AU4647000A/en not_active Abandoned
- 2000-04-18 JP JP2000613434A patent/JP2002542289A/ja not_active Withdrawn
- 2000-04-18 EA EA200101112A patent/EA004435B1/ru not_active IP Right Cessation
- 2000-04-18 EE EEP200100555A patent/EE200100555A/xx unknown
- 2000-04-18 ES ES00928200T patent/ES2256005T3/es not_active Expired - Lifetime
- 2000-04-18 CN CN00807935A patent/CN1351492A/zh active Pending
- 2000-04-18 BR BR0010689-5A patent/BR0010689A/pt not_active IP Right Cessation
- 2000-04-18 AP APAP/P/2001/002324A patent/AP2001002324A0/en unknown
- 2000-04-18 CA CA002370639A patent/CA2370639A1/en not_active Abandoned
- 2000-04-18 HU HU0201016A patent/HUP0201016A3/hu unknown
- 2000-04-18 AT AT00928200T patent/ATE314846T1/de not_active IP Right Cessation
- 2000-04-18 OA OA1200100272A patent/OA11870A/en unknown
- 2000-04-18 DE DE60025344T patent/DE60025344T2/de not_active Expired - Fee Related
- 2000-04-18 IL IL14608500A patent/IL146085A0/xx unknown
- 2000-04-18 PT PT00928200T patent/PT1173172E/pt unknown
- 2000-04-18 DK DK00928200T patent/DK1173172T3/da active
- 2000-04-18 EP EP00928200A patent/EP1173172B1/de not_active Expired - Lifetime
- 2000-04-18 WO PCT/US2000/010465 patent/WO2000064443A1/en active IP Right Grant
- 2000-04-18 SK SK1538-2001A patent/SK15382001A3/sk unknown
- 2000-04-19 PE PE2000000374A patent/PE20010055A1/es not_active Application Discontinuation
- 2000-04-21 TN TNTNSN00085A patent/TNSN00085A1/fr unknown
- 2000-04-24 UY UY26118A patent/UY26118A1/es unknown
- 2000-04-25 SV SV2000000058A patent/SV2002000058A/es unknown
-
2001
- 2001-10-19 IS IS6118A patent/IS6118A/is unknown
- 2001-10-19 NO NO20015128A patent/NO20015128L/no not_active Application Discontinuation
- 2001-11-16 BG BG106115A patent/BG106115A/bg unknown
-
2002
- 2002-07-19 HK HK02105343.1A patent/HK1043741A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070037860A1 (en) | Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy | |
KR100586754B1 (ko) | 지단백질 산화의 억제 | |
Napoli et al. | Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension | |
Prasad | C‐reactive protein (CRP)‐lowering agents | |
AU2002211452B2 (en) | Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases | |
KR101494067B1 (ko) | 부작용을 최소화하면서 과지질혈증 및 과콜레스테롤혈증과 연관된 질환 또는 질병의 치료 방법 | |
KR100200467B1 (ko) | 콜레스테롤 저하제 및 ace 억제제로 이루어진 아테롬성 동맥경화증의 예방, 안정화 또는 경감용 조성물 | |
Golper et al. | Lovastatin in the treatment of multifactorial hyperlipidemia associated with proteinuria | |
US20020052394A1 (en) | Synergistic effect of amlodipine and atorvastatin on cholesterol crystal formation inhibition and aortic endothelial cell nitric oxide release | |
Jorge et al. | Rapid reversal of endothelial dysfunction in hypercholesterolaemic rabbits treated with simvastatin and pravastatin | |
BG106115A (bg) | Синергичните ефекти на амлодипин и аторвастатин метаболит като база за комбинирана терапия | |
Illingworth | New horizons in combination drug therapy for hypercholesterolemia | |
Lapenna et al. | Antioxidant activity of amiodarone on human lipoprotein oxidation | |
JP2002542289A5 (de) | ||
Fleckenstein-Grün et al. | Role of calcium in arteriosclerosis—experimental evaluation of antiarteriosclerotic potencies of Ca antagonists | |
MXPA01010694A (en) | Synergistic effects of amlodipine and atorvastatin | |
MXPA00003200A (en) | Inhibtion of lipoprotein oxidation | |
TSAI et al. | Comparison of pravastatin alone and with cholestyramine in the treatment of hypercholesterolemia |